DaVita’s Inpatient Hospital Services Program Reaccredited for Ambulatory Health Care by The Joint Commission

October 8, 2018 |

3 min read

DaVita Hospital Services continues to deliver on quality with second reaccreditation

DENVER, Oct. 8, 2018 /PRNewswire/ -- DaVita Kidney Care, a division of DaVita Inc. (NYSE: DVA), a leading independent provider of integrated health and kidney care services in the United States, today announced DaVita Hospital Services has received its second reaccreditation for Ambulatory Health Care from The Joint Commission.

“Our hospital partners ask us to bring our operations excellence and demonstrated quality of patient care to the inpatient care setting, and we’re thrilled to be recognized for delivering on that promise,” said Tina Livaudais, Vice President, Clinical Services for DaVita Hospital Services Group. “Our care team is one of the best in kidney care, and I’m pleased to have the chance today to acknowledge their enormous contributions to our reaccreditation.”

The reaccreditation, effective 2018, is a symbol of quality earned by DaVita Hospital Services for meeting or exceeding performance standards set by The Joint Commission. Reaccreditation focuses on enhancing the quality and safety of patient care through improved clinical outcomes and performance metrics, risk management and survey preparedness.

DaVita was the first inpatient dialysis provider to be accredited by The Joint Commission in 2013. The Joint Commission collaborated to outline national industry standards by which safety and quality of inpatient kidney disease and apheresis therapies would be measured in the future. Having set standards allowed DaVita to better measure performance and increase alignment with its hospital partners.

“Joint Commission accreditation provides ambulatory care organizations with the processes contributing to improvements in a variety of areas from the enhancement of staff education to the demonstration of leading practices within the ambulatory setting,” said Pearl Darling, MBA, Executive Director, Ambulatory Care Services, The Joint Commission. “We commend DaVita and its staff for achieving this pinnacle demonstrating a commitment to patient safety and quality. Your passion, dedication and tenacity can ultimately improve patient care. Thank you for your commitment to patient safety and entrusting The Joint Commission to assist you.”

To learn more about DaVita Hospital Services, visit DaVita.com/Hospitals.

About DaVita Kidney Care
DaVita Kidney Care is a division of DaVita Inc., a Fortune 500® company, that through its operating divisions provides a variety of health care services to patient populations throughout the United States and abroad. A leading provider of dialysis services in the United States, DaVita Kidney Care treats patients with chronic kidney failure and end stage renal disease. DaVita Kidney Care strives to improve patients’ quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. As of June 30, 2018, DaVita Kidney Care operated or provided administrative services at 2,580 outpatient dialysis centers located in the United States serving approximately 201,000 patients. The company also operated 253 outpatient dialysis centers located in 10 countries outside the United States. DaVita Kidney Care supports numerous programs dedicated to creating positive, sustainable change in communities around the world. The company’s leadership development initiatives and social responsibility efforts have been recognized by Fortune, Modern Healthcare, Newsweek and WorldBlu. For more information, please visit DaVita.com.

Contact Information

Media:
Halie Peddle
Halie.Peddle@DaVita.com
(303) 550-6349

DaVita logo (PRNewsfoto/DaVita)